These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23407349)

  • 1. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.
    Toyota K; Hashimoto T; Ogino D; Matsunaga A; Ito M; Masakane I; Degawa N; Sato H; Shirai S; Umetsu K; Tamiya G; Saito T; Hayasaka K
    J Hum Genet; 2013 May; 58(5):254-8. PubMed ID: 23407349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T; Matsunaga A; Oikawa S
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
    Han HL; Lin S; Sun LS; Zhang P; Zhai DP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation.
    Hu Z; Huang S; Wu Y; Liu Y; Liu X; Su D; Tao Y; Fu P; Zhang X; Peng Z; Zhang S; Yang Y
    Kidney Int; 2014 Feb; 85(2):416-24. PubMed ID: 24025644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
    Ishimura A; Watanabe M; Nakashima H; Ito K; Miyake K; Mochizuki S; Ishigaki Y; Saito T
    Clin Exp Nephrol; 2009 Oct; 13(5):430-437. PubMed ID: 19459027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
    Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
    J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.
    Saito T; Oikawa S; Sato H; Sato T; Ito S; Sasaki J
    Kidney Int Suppl; 1999 Jul; 71():S37-41. PubMed ID: 10412734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H; Yang Y; Hu Z
    J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topics in lipoprotein glomerulopathy: an overview.
    Saito T; Matsunaga A; Ito K; Nakashima H
    Clin Exp Nephrol; 2014 Apr; 18(2):214-7. PubMed ID: 24149835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.
    Lendon CL; Martinez A; Behrens IM; Kosik KS; Madrigal L; Norton J; Neuman R; Myers A; Busfield F; Wragg M; Arcos M; Arango Viana JC; Ossa J; Ruiz A; Goate AM; Lopera F
    Hum Mutat; 1997; 10(3):186-95. PubMed ID: 9298817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice.
    Ishigaki Y; Oikawa S; Suzuki T; Usui S; Magoori K; Kim DH; Suzuki H; Sasaki J; Sasano H; Okazaki M; Toyota T; Saito T; Yamamoto TT
    J Biol Chem; 2000 Oct; 275(40):31269-73. PubMed ID: 10903326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
    da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
    Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.
    Yang M; Weng Q; Pan X; Hussain HMJ; Yu S; Xu J; Yu X; Liu Y; Jin Y; Zhang C; Li X; Ren H; Chen N; Xie J
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1281. PubMed ID: 32441489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
    Garritano S; Gemignani F; Palmero EI; Olivier M; Martel-Planche G; Le Calvez-Kelm F; Brugiéres L; Vargas FR; Brentani RR; Ashton-Prolla P; Landi S; Tavtigian SV; Hainaut P; Achatz MI
    Hum Mutat; 2010 Feb; 31(2):143-50. PubMed ID: 19877175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice.
    Wu H; Yang J; Liu YQ; Lei S; Yang M; Yang Z; Yang Y; Hu Z
    J Transl Med; 2021 Mar; 19(1):97. PubMed ID: 33663537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.